Market Research Logo

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018 provides an overview of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Overview
3 Products under Development
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials
4 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
5 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies and Product Overview
5.1 Andramed GmbH Company Overview
5.2 Boston Scientific Corp Company Overview
5.3 C. R. Bard Inc Company Overview
5.4 Cagent Vascular LLC Company Overview
5.5 Contego Medical, LLC Company Overview
5.6 Hexacath SA Company Overview
5.7 Medtronic plc Company Overview
5.8 MicroPort Scientific Corp Company Overview
5.9 Minnesota Health Solutions Corporation Company Overview
5.10 NuVascular Technologies Inc Company Overview
5.11 QT Vascular Ltd Company Overview
5.12 SurModics Inc Company Overview
5.13 Terumo Corp Company Overview
5.14 Terumo Europe NV Company Overview
6 Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters- Recent Developments
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC
6.3 May 16, 2018: Surmodics Announces Leadership Change and Appointment of Interim CFO
6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.5 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
6.8 May 03, 2018: Teleflex Reports First Quarter 2018 Results
6.9 May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
6.10 May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.12 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.13 Apr 23, 2018: Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.15 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018
6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.17 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.18 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
6.20 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.21 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
6.22 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.23 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.25 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices
6.26 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.27 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.28 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017
6.29 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017
6.30 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition
6.31 Dec 22, 2017: Kaneka releasing a high-pressure balloon catheter to enlarge peripheral vessels
6.32 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.33 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems
6.34 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.35 Dec 04, 2017: Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval
6.36 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.37 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
6.38 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.39 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.40 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results
6.41 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.42 Oct 25, 2017: Bard Announces Third Quarter Results
6.43 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.44 Oct 12, 2017: STENTYS: Revenues for the Third Quarter of 2017: Continued Growth for the Xposition S Stent
6.45 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria
6.46 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.47 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.48 Oct 02, 2017: STENTYS: 2017 half-year results
6.49 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California
6.50 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
6.51 Sep 18, 2017: Surmodics Announces Global Approvals of .014 Low-Profile PTA Balloon Dilation Catheter
6.52 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.53 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.54 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.55 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
6.56 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results
6.57 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million
6.58 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.59 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
6.60 Jul 24, 2017: Reewarm Gains CFDA Approval
6.61 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.62 Jul 12, 2017: STENTYS: Revenues Of €1.7 Million in the Second Quarter Of 2017
6.63 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.64 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.65 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Table 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Table 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Table 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials
Table 6: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters Companies - Pipeline Products by Stage of Development
Table 7: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Zero-Profile PTA Balloon - Product Status
Table 10: Zero-Profile PTA Balloon - Product Description
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Drug Coated Balloon - Below-The-Knee (BTK) - Product Status
Table 13: Drug Coated Balloon - Below-The-Knee (BTK) - Product Description
Table 14: Next Generation 0.018” Balloon - Product Status
Table 15: Next Generation 0.018” Balloon - Product Description
Table 16: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Status
Table 18: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - Product Description
Table 19: C. R. Bard Inc - Ongoing Clinical Trials Overview
Table 20: LUTONIX 035 Drug Coated Balloon PTA Catheter - Long Femoropopliteal Lesions - A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
Table 21: Cagent Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Serranator Bass - Product Status
Table 23: Serranator Bass - Product Description
Table 24: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 25: PALADIN - Product Status
Table 26: PALADIN - Product Description
Table 27: Superficial Femoral Artery Balloon - Product Status
Table 28: Superficial Femoral Artery Balloon - Product Description
Table 29: Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview
Table 30: MERAK PTA Dilatation Catheter - Product Status
Table 31: MERAK PTA Dilatation Catheter - Product Description
Table 32: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Chocolate PTA Balloon Catheter - Product Status
Table 34: Chocolate PTA Balloon Catheter - Product Description
Table 35: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Reewarm14 - Product Status
Table 37: Reewarm14 - Product Description
Table 38: Reewarm18 Peripheral Balloon Dilation Catheter - Product Status
Table 39: Reewarm18 Peripheral Balloon Dilation Catheter - Product Description
Table 40: Minnesota Health Solutions Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Balloon Angioplasty Inflation Device - Product Status
Table 42: Balloon Angioplasty Inflation Device - Product Description
Table 43: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: NuSpun DE Balloon - Product Status
Table 45: NuSpun DE Balloon - Product Description
Table 46: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Silk PTA Balloon Catheter - Product Status
Table 48: Silk PTA Balloon Catheter - Product Description
Table 49: SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: 0.018” OTW Dual Lumen PTA Catheter - Product Status
Table 51: 0.018” OTW Dual Lumen PTA Catheter - Product Description
Table 52: 0.018” RX Dual Lumen PTA Catheter - Product Status
Table 53: 0.018” RX Dual Lumen PTA Catheter - Product Description
Table 54: 0.035” Large Diameter OTW PTA Catheter - Product Status
Table 55: 0.035” Large Diameter OTW PTA Catheter - Product Description
Table 56: 0.035” Next Generation Workhorse PTA Catheter - Product Status
Table 57: 0.035” Next Generation Workhorse PTA Catheter - Product Description
Table 58: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 59: TRI PTA Balloon - Product Status
Table 60: TRI PTA Balloon - Product Description
Table 61: Terumo Europe NV Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Kanshas Drug Coated Balloon - Product Status
Table 63: Kanshas Drug Coated Balloon - Product Description
Table 64: Terumo Europe NV - Ongoing Clinical Trials Overview
Table 65: Kanshas Drug Coated Balloon - Prospective, Multi-Center, Open, Single Arm Study for the Treatment of Patients Presenting De Novo Lesions in the Superficial Femoral or Popliteal Arteries Using a Kanshas Drug Coated Balloon Catheter
Table 66: Glossary
1.2 List of Figures
Figure 1: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Territory
Figure 3: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Regulatory Path
Figure 4: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Pipeline Products by Estimated Approval Date
Figure 5: Percutaneous Transluminal Angioplasty (PTA) Balloons Catheters - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report